The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis
Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activi...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2000-06, Vol.275 (22), p.16450 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 22 |
container_start_page | 16450 |
container_title | The Journal of biological chemistry |
container_volume | 275 |
creator | Mukhina, S Stepanova, V Traktouev, D Poliakov, A Beabealashvilly, R Gursky, Y Minashkin, M Shevelev, A Tkachuk, V |
description | Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt), inactive urokinase with single mutation (His(204) to Gln) (r-uPA(H/Q)), urokinase with mutation of His(204) to Gln together with a deletion of growth factor-like domain (r-uPA(H/Q)-GFD), the catalytic domain of urokinase (r-uPA(LMW)), and its kringle domain (r-KD) were expressed in Escherichia coli. We demonstrate that glycosylated uPA, r-uPAwt, r-uPA(H/Q), and r-uPA(H/Q)-GFD elicited similar chemotactic effects. Half-maximal chemotaxis (EC(50)) were apparent at approximately 2 nm with all the uPA variants. The kringle domain induced cell migration with an EC(50) of about 6 nm, whereas the denaturated r-KD and r-uPA(LMW) were without effect. R-uPAwt-induced chemotaxis was dependent on an association with uPAR and a uPA-kringle domain-binding site, determined using a monoclonal uPAR antibody to prevent the uPA-uPAR interaction, and a monoclonal antibody to the uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was due to interaction with a high affinity binding site on the uPAR, and a lower affinity binding site on an unidentified cell surface target, which was mediated exclusively through the kringle domain of urokinase. Specific binding of r-uPA(H/Q)-GFD to hAWSMC involved an interaction with a single site whose characteristics were similar to those of the low affinity site of r-uPAwt binding to hAWSMC. uPAR-deficient HEK 293 cells specifically bound r-uPAwt and r-uPA(H/Q)-GFD via a single, similar type of binding site. These cells migrated when stimulated by r-uPA(H/Q)-GFD and uPAwt, but not r-uPA(LMW). HEK 293 cells transfected with the uPAR cDNA expressed two classes of sites that bound r-uPAwt; however, only a single site was responsible for the binding of r-uPA(H/Q)-GFD. Together, these findings indicate that uPA-induced chemotaxis is dependent on the binding of the uPA-kringle to the membrane surface of cells and the association of uPA with uPAR. |
doi_str_mv | 10.1074/jbc.M909080199 |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_10749881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10749881</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-b8ec0c0b76ef78019f2787b29fb5fedd6aef66d296bf4b3399d365b6a76bcb5d3</originalsourceid><addsrcrecordid>eNo1kMtOwzAQRb0A0VLYskT-gRQnaex4iSpeUhGbsq78GBO3iR3ZjgR8DN9KQuksZnSlM3ceCN3kZJkTtrrbS7V85YSTmuScn6E5IUWe8aKqZ-gyxj0ZY8XzCzSbcF7X-Rz9bBvAqoHOJ6GSVXjK3mFv8BD8wToRAY86dt6nBndDVO3YAG0bsY1YQw9Og0sTY1PEh2Ddx0ho3wnrlnjdiDBaQrDf4mRs3aiPcyIWTmPlXQpWDn9A8qd9Pm28QudGtBGu_-sCvT8-bNfP2ebt6WV9v8n6grCUyRoUUUQyCoZN15uC1UwW3MjKgNZUgKFUF5xKs5JlybkuaSWpYFQqWelygW6Pvv0gO9C7PthOhK_d6VHlL9NVbmY</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mukhina, S ; Stepanova, V ; Traktouev, D ; Poliakov, A ; Beabealashvilly, R ; Gursky, Y ; Minashkin, M ; Shevelev, A ; Tkachuk, V</creator><creatorcontrib>Mukhina, S ; Stepanova, V ; Traktouev, D ; Poliakov, A ; Beabealashvilly, R ; Gursky, Y ; Minashkin, M ; Shevelev, A ; Tkachuk, V</creatorcontrib><description>Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt), inactive urokinase with single mutation (His(204) to Gln) (r-uPA(H/Q)), urokinase with mutation of His(204) to Gln together with a deletion of growth factor-like domain (r-uPA(H/Q)-GFD), the catalytic domain of urokinase (r-uPA(LMW)), and its kringle domain (r-KD) were expressed in Escherichia coli. We demonstrate that glycosylated uPA, r-uPAwt, r-uPA(H/Q), and r-uPA(H/Q)-GFD elicited similar chemotactic effects. Half-maximal chemotaxis (EC(50)) were apparent at approximately 2 nm with all the uPA variants. The kringle domain induced cell migration with an EC(50) of about 6 nm, whereas the denaturated r-KD and r-uPA(LMW) were without effect. R-uPAwt-induced chemotaxis was dependent on an association with uPAR and a uPA-kringle domain-binding site, determined using a monoclonal uPAR antibody to prevent the uPA-uPAR interaction, and a monoclonal antibody to the uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was due to interaction with a high affinity binding site on the uPAR, and a lower affinity binding site on an unidentified cell surface target, which was mediated exclusively through the kringle domain of urokinase. Specific binding of r-uPA(H/Q)-GFD to hAWSMC involved an interaction with a single site whose characteristics were similar to those of the low affinity site of r-uPAwt binding to hAWSMC. uPAR-deficient HEK 293 cells specifically bound r-uPAwt and r-uPA(H/Q)-GFD via a single, similar type of binding site. These cells migrated when stimulated by r-uPA(H/Q)-GFD and uPAwt, but not r-uPA(LMW). HEK 293 cells transfected with the uPAR cDNA expressed two classes of sites that bound r-uPAwt; however, only a single site was responsible for the binding of r-uPA(H/Q)-GFD. Together, these findings indicate that uPA-induced chemotaxis is dependent on the binding of the uPA-kringle to the membrane surface of cells and the association of uPA with uPAR.</description><identifier>ISSN: 0021-9258</identifier><identifier>DOI: 10.1074/jbc.M909080199</identifier><identifier>PMID: 10749881</identifier><language>eng</language><publisher>United States</publisher><subject>Amino Acid Sequence ; Cell Line ; Chemotaxis - drug effects ; Humans ; Kringles - physiology ; Molecular Sequence Data ; Muscle, Smooth - cytology ; Muscle, Smooth - drug effects ; Mutagenesis ; Protein Binding ; Recombinant Proteins - genetics ; Recombinant Proteins - metabolism ; Recombinant Proteins - pharmacology ; Urokinase-Type Plasminogen Activator - genetics ; Urokinase-Type Plasminogen Activator - metabolism ; Urokinase-Type Plasminogen Activator - pharmacology</subject><ispartof>The Journal of biological chemistry, 2000-06, Vol.275 (22), p.16450</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10749881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mukhina, S</creatorcontrib><creatorcontrib>Stepanova, V</creatorcontrib><creatorcontrib>Traktouev, D</creatorcontrib><creatorcontrib>Poliakov, A</creatorcontrib><creatorcontrib>Beabealashvilly, R</creatorcontrib><creatorcontrib>Gursky, Y</creatorcontrib><creatorcontrib>Minashkin, M</creatorcontrib><creatorcontrib>Shevelev, A</creatorcontrib><creatorcontrib>Tkachuk, V</creatorcontrib><title>The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt), inactive urokinase with single mutation (His(204) to Gln) (r-uPA(H/Q)), urokinase with mutation of His(204) to Gln together with a deletion of growth factor-like domain (r-uPA(H/Q)-GFD), the catalytic domain of urokinase (r-uPA(LMW)), and its kringle domain (r-KD) were expressed in Escherichia coli. We demonstrate that glycosylated uPA, r-uPAwt, r-uPA(H/Q), and r-uPA(H/Q)-GFD elicited similar chemotactic effects. Half-maximal chemotaxis (EC(50)) were apparent at approximately 2 nm with all the uPA variants. The kringle domain induced cell migration with an EC(50) of about 6 nm, whereas the denaturated r-KD and r-uPA(LMW) were without effect. R-uPAwt-induced chemotaxis was dependent on an association with uPAR and a uPA-kringle domain-binding site, determined using a monoclonal uPAR antibody to prevent the uPA-uPAR interaction, and a monoclonal antibody to the uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was due to interaction with a high affinity binding site on the uPAR, and a lower affinity binding site on an unidentified cell surface target, which was mediated exclusively through the kringle domain of urokinase. Specific binding of r-uPA(H/Q)-GFD to hAWSMC involved an interaction with a single site whose characteristics were similar to those of the low affinity site of r-uPAwt binding to hAWSMC. uPAR-deficient HEK 293 cells specifically bound r-uPAwt and r-uPA(H/Q)-GFD via a single, similar type of binding site. These cells migrated when stimulated by r-uPA(H/Q)-GFD and uPAwt, but not r-uPA(LMW). HEK 293 cells transfected with the uPAR cDNA expressed two classes of sites that bound r-uPAwt; however, only a single site was responsible for the binding of r-uPA(H/Q)-GFD. Together, these findings indicate that uPA-induced chemotaxis is dependent on the binding of the uPA-kringle to the membrane surface of cells and the association of uPA with uPAR.</description><subject>Amino Acid Sequence</subject><subject>Cell Line</subject><subject>Chemotaxis - drug effects</subject><subject>Humans</subject><subject>Kringles - physiology</subject><subject>Molecular Sequence Data</subject><subject>Muscle, Smooth - cytology</subject><subject>Muscle, Smooth - drug effects</subject><subject>Mutagenesis</subject><subject>Protein Binding</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - metabolism</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><subject>Urokinase-Type Plasminogen Activator - pharmacology</subject><issn>0021-9258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kMtOwzAQRb0A0VLYskT-gRQnaex4iSpeUhGbsq78GBO3iR3ZjgR8DN9KQuksZnSlM3ceCN3kZJkTtrrbS7V85YSTmuScn6E5IUWe8aKqZ-gyxj0ZY8XzCzSbcF7X-Rz9bBvAqoHOJ6GSVXjK3mFv8BD8wToRAY86dt6nBndDVO3YAG0bsY1YQw9Og0sTY1PEh2Ddx0ho3wnrlnjdiDBaQrDf4mRs3aiPcyIWTmPlXQpWDn9A8qd9Pm28QudGtBGu_-sCvT8-bNfP2ebt6WV9v8n6grCUyRoUUUQyCoZN15uC1UwW3MjKgNZUgKFUF5xKs5JlybkuaSWpYFQqWelygW6Pvv0gO9C7PthOhK_d6VHlL9NVbmY</recordid><startdate>20000602</startdate><enddate>20000602</enddate><creator>Mukhina, S</creator><creator>Stepanova, V</creator><creator>Traktouev, D</creator><creator>Poliakov, A</creator><creator>Beabealashvilly, R</creator><creator>Gursky, Y</creator><creator>Minashkin, M</creator><creator>Shevelev, A</creator><creator>Tkachuk, V</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20000602</creationdate><title>The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis</title><author>Mukhina, S ; Stepanova, V ; Traktouev, D ; Poliakov, A ; Beabealashvilly, R ; Gursky, Y ; Minashkin, M ; Shevelev, A ; Tkachuk, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-b8ec0c0b76ef78019f2787b29fb5fedd6aef66d296bf4b3399d365b6a76bcb5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Amino Acid Sequence</topic><topic>Cell Line</topic><topic>Chemotaxis - drug effects</topic><topic>Humans</topic><topic>Kringles - physiology</topic><topic>Molecular Sequence Data</topic><topic>Muscle, Smooth - cytology</topic><topic>Muscle, Smooth - drug effects</topic><topic>Mutagenesis</topic><topic>Protein Binding</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - metabolism</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><topic>Urokinase-Type Plasminogen Activator - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhina, S</creatorcontrib><creatorcontrib>Stepanova, V</creatorcontrib><creatorcontrib>Traktouev, D</creatorcontrib><creatorcontrib>Poliakov, A</creatorcontrib><creatorcontrib>Beabealashvilly, R</creatorcontrib><creatorcontrib>Gursky, Y</creatorcontrib><creatorcontrib>Minashkin, M</creatorcontrib><creatorcontrib>Shevelev, A</creatorcontrib><creatorcontrib>Tkachuk, V</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhina, S</au><au>Stepanova, V</au><au>Traktouev, D</au><au>Poliakov, A</au><au>Beabealashvilly, R</au><au>Gursky, Y</au><au>Minashkin, M</au><au>Shevelev, A</au><au>Tkachuk, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2000-06-02</date><risdate>2000</risdate><volume>275</volume><issue>22</issue><spage>16450</spage><pages>16450-</pages><issn>0021-9258</issn><abstract>Urokinase plasminogen activator (uPA) is thought to exert its effects on cell growth, adhesion, and migration by mechanisms involving proteolysis and interaction with its cell surface receptor (uPAR). The functional properties of uPA and the significance of its various domains for chemotactic activity were analyzed using human airway smooth muscle cells (hAWSMC). The wild-type uPA (r-uPAwt), inactive urokinase with single mutation (His(204) to Gln) (r-uPA(H/Q)), urokinase with mutation of His(204) to Gln together with a deletion of growth factor-like domain (r-uPA(H/Q)-GFD), the catalytic domain of urokinase (r-uPA(LMW)), and its kringle domain (r-KD) were expressed in Escherichia coli. We demonstrate that glycosylated uPA, r-uPAwt, r-uPA(H/Q), and r-uPA(H/Q)-GFD elicited similar chemotactic effects. Half-maximal chemotaxis (EC(50)) were apparent at approximately 2 nm with all the uPA variants. The kringle domain induced cell migration with an EC(50) of about 6 nm, whereas the denaturated r-KD and r-uPA(LMW) were without effect. R-uPAwt-induced chemotaxis was dependent on an association with uPAR and a uPA-kringle domain-binding site, determined using a monoclonal uPAR antibody to prevent the uPA-uPAR interaction, and a monoclonal antibody to the uPA-kringle domain. The binding of iodinated r-uPAwt with hAWSMC was due to interaction with a high affinity binding site on the uPAR, and a lower affinity binding site on an unidentified cell surface target, which was mediated exclusively through the kringle domain of urokinase. Specific binding of r-uPA(H/Q)-GFD to hAWSMC involved an interaction with a single site whose characteristics were similar to those of the low affinity site of r-uPAwt binding to hAWSMC. uPAR-deficient HEK 293 cells specifically bound r-uPAwt and r-uPA(H/Q)-GFD via a single, similar type of binding site. These cells migrated when stimulated by r-uPA(H/Q)-GFD and uPAwt, but not r-uPA(LMW). HEK 293 cells transfected with the uPAR cDNA expressed two classes of sites that bound r-uPAwt; however, only a single site was responsible for the binding of r-uPA(H/Q)-GFD. Together, these findings indicate that uPA-induced chemotaxis is dependent on the binding of the uPA-kringle to the membrane surface of cells and the association of uPA with uPAR.</abstract><cop>United States</cop><pmid>10749881</pmid><doi>10.1074/jbc.M909080199</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2000-06, Vol.275 (22), p.16450 |
issn | 0021-9258 |
language | eng |
recordid | cdi_pubmed_primary_10749881 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Amino Acid Sequence Cell Line Chemotaxis - drug effects Humans Kringles - physiology Molecular Sequence Data Muscle, Smooth - cytology Muscle, Smooth - drug effects Mutagenesis Protein Binding Recombinant Proteins - genetics Recombinant Proteins - metabolism Recombinant Proteins - pharmacology Urokinase-Type Plasminogen Activator - genetics Urokinase-Type Plasminogen Activator - metabolism Urokinase-Type Plasminogen Activator - pharmacology |
title | The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A52%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20chemotactic%20action%20of%20urokinase%20on%20smooth%20muscle%20cells%20is%20dependent%20on%20its%20kringle%20domain.%20Characterization%20of%20interactions%20and%20contribution%20to%20chemotaxis&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Mukhina,%20S&rft.date=2000-06-02&rft.volume=275&rft.issue=22&rft.spage=16450&rft.pages=16450-&rft.issn=0021-9258&rft_id=info:doi/10.1074/jbc.M909080199&rft_dat=%3Cpubmed%3E10749881%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10749881&rfr_iscdi=true |